Patent · US Active

Compounds and methods for modulating interleukin-2-inducible t-cell kinase

US11008314B2 · kind B2 · utility

1Cited by
2References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 3, 2017
Grant dateMay 18, 2021
Priority date—
Expiry dateNov 3, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D495/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein, inter alia, are methods and compounds for modulating Interleukin-2-inducible T-cell kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.